Welcome to our dedicated page for Cvs Health news (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on Cvs Health stock.
News about CVS Health Corporation (NYSE: CVS) covers developments across its roles in retail pharmacy, pharmacy benefit management, health insurance and health care delivery. Company press releases and related disclosures highlight how CVS Health communicates financial performance, strategic priorities, governance updates and community initiatives to investors, customers and the public.
Investors following CVS stock can find news on quarterly and full-year earnings announcements, financial guidance updates and Investor Day presentations. For example, CVS Health has issued press releases discussing results for specific quarters, updating full-year financial guidance and providing outlooks for future years, including projections for revenues, operating income, adjusted operating income, GAAP diluted earnings (loss) per share and adjusted EPS. These communications often appear in conjunction with Form 8-K filings that furnish the underlying press releases.
Corporate governance and leadership changes are another recurring news theme. CVS Health has announced Board decisions such as appointing its President and Chief Executive Officer, J. David Joyner, to the additional role of Chair of the Board, and it has used both press releases and Form 8-K filings to describe these actions and related Board structures.
Operational and community-focused news items describe how CVS Health engages with public health and local organizations. Examples include offering the measles-mumps-rubella (MMR) vaccine at select CVS Pharmacy and MinuteClinic locations in South Carolina during a measles outbreak, and the CVS Health Foundation’s grants to the American Diabetes Association to expand a maternal diabetes program in New York City. Other stories highlight investments in affordable housing projects and the company’s reported economic impact across U.S. states.
Visitors to this news page can review these types of announcements to understand how CVS Health presents its strategy, financial outlook, health services, community partnerships and responses to health challenges over time.
Omnicare (NYSE: CVS) entered an asset purchase agreement with GenieRx, which will act as the stalking horse bidder in Omnicare's court‑supervised sale process.
The bid establishes a sale floor; competing bids are due April 30, 2026, an auction is expected May 5, 2026, and a court hearing to approve the winning bid will follow. Omnicare says it will continue serving skilled nursing and assisted living customers during the process.
CVS (NYSE:CVS) opened its first pharmacy-only location in Chicago on March 30, 2026, part of a plan to open nearly 20 pharmacy-only sites this year and more than 40 new CVS Pharmacy locations including traditional and Target stores. Sites average ~3,000 sq ft and focus on prescriptions, immunizations and pharmacist counseling.
The format complements existing store types and targets communities needing increased access to in-person pharmacy care.
CVS Health (NYSE: CVS) declared a quarterly dividend of $0.665 per share. The board approved the payment, which is payable on May 4, 2026 to shareholders of record on April 23, 2026.
This announcement details the dividend amount, record date, and payment date for common stockholders.
CVS Health (NYSE:CVS) is investing $2.24 million to launch a Health Zone in Charlotte's Historic West End through the Westside Wellness Collab led by LISC Charlotte.
The three‑year effort funds mobile clinics, fresh food distribution, care coordination and partner capacity building to improve chronic‑condition support and food access.
CVS Health (NYSE:CVS) announced a $2.24 million investment in Health Impact Ohio to launch a Health Zone in Columbus on March 10, 2026. The funding expands Community Health Worker capacity, maternal and behavioral health services, training and data systems to reduce avoidable emergency care and improve care coordination.
The investment builds on CVS's broader Ohio footprint, including workforce centers, affordable housing investments (~$80 million) and reported FY2024 economic contributions.
CVS Health (NYSE: CVS) and Google Cloud announced a strategic partnership to launch Health100, an AI-native consumer engagement platform aimed at creating a connected, proactive, and personalized health experience. The platform will use Google Cloud technologies including Gemini models, Cloud Healthcare API, and BigQuery.
Health100 is designed to enable real-time, omni-channel support, pharmacist-led care management, cost transparency, and future biometric wearable integration. Initial launch is planned for 2026 with a first look at The Check Up in March 2026.
CVS (NYSE:CVS) became an Official Health and Wellness Partner of the U.S. Soccer Federation and the National Women's Soccer League on Feb 19, 2026, backing a multi-year program to develop community multi-use soccer fields in select U.S. markets through 2028.
The sponsorship also includes club partnerships with Washington Spirit, Seattle Reign FC and Kansas City Current and community programs amplified by athletes and ambassadors.
CVS Health (NYSE: CVS) announced a $5 million scholarship program to support students pursuing a Doctor of Pharmacy (PharmD) at Xavier University of Louisiana and the University of Louisiana at Monroe.
The program aims to reduce financial barriers, strengthen Louisiana's pharmacy workforce, and expand access to care, starting in the 2026-27 academic year.
CVS Health (NYSE: CVS) reported fourth-quarter and full-year 2025 results with total revenues of $105.7B (Q4, +8.2% YoY) and a record $402.1B for the year (+7.8% YoY). GAAP diluted EPS was $2.30 in Q4 and $1.39 for the year; adjusted EPS was $1.09 in Q4 and $6.75 for the year.
The company generated $10.6B of operating cash flow in 2025, completed pharmacy reimbursement transitions, and cited $5.7B goodwill impairment and ~$1.2B legacy litigation charges that reduced operating income. 2026 adjusted EPS guidance: $7.00–$7.20; GAAP EPS guidance: $5.94–$6.14.
CVS (NYSE: CVS) announced that about 9,000 CVS Pharmacy locations now accept TrumpRx discount cards, allowing eligible patients to apply manufacturer-determined savings at the pharmacy counter.
CVS notes its 27,000 community pharmacists can help customers, and that CVS Specialty and NovoCare support reduced pricing for fertility medications via the TrumpRx Fertility program.